Dr. Sanjay Gupta: Why Haven’t We Cured the Common Cold?
The average person gets two to four colds a year. With all the missed school and work, that adds up to an economic impact of…
Thought Leader: Sanjay Gupta
By Scott Gottlieb (Original source The Hill)
“During his Senate confirmation hearing in April 2017, Dr. Scott Gottlieb committed himself to “the gold standard of safety and efficacy.”
Over the past two years as head of the Food and Drug Administration (FDA), Commissioner Gottlieb has made good on that promise, and his tenure has been a model for future FDA chiefs.
To his great credit and the benefit of consumers, Gottlieb, whose tenure at the agency ended recently, pursued policies that encouraged competition and choice.
In fall 2016, months before his appointment as FDA chief, Gottlieb foreshadowed his approach to the FDA in testimony at a Senate hearing on the EpiPen price scandal.”
Click here to see more
Dr. Sanjay Gupta: Why Haven’t We Cured the Common Cold?
The average person gets two to four colds a year. With all the missed school and work, that adds up to an economic impact of…
Thought Leader: Sanjay Gupta
Erika Ayers Badan: How to Keep Creativity Alive
Hi! Ever felt like you’re on a Disney ride through every big-company headache imaginable? Think lawyers, bankers, finance goons, stale conference rooms, staid conversations and…
Thought Leader: Erika Ayers Badan
Chris Miller: Trump’s Nvidia Chip Decision Lands Hard
In a new article, “Allowing China access to advanced semiconductors puts national security and U.S. AI industry at risk,”Chris Miller — author of Chip War…
Thought Leader: Chris Miller